Oasis Medical Recalls HPMC Visoelastic Due to pH Specification Failure
Oasis Medical, Inc. is recalling HPMC Visoelastic syringes because the pH of the affected lots may not meet specifications at expiry.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for documentation or specification issues.
Plain-English summary
Oasis Medical, Inc. is recalling 15,301 units of HPMC Visoelastic, 20,000 cps, 2.0 mL in 3-mL Syringe. The recall covers specific lots with expiration dates ranging from August 2016 to May 2017. The product was distributed nationwide and in several international locations, including Saudi Arabia, Israel, Chile, Norway, Ecuador, Greece, Switzerland, Canada, England, Colombia, Poland, South Africa, Germany, Pakistan, El Salvador, Dubai, and Belgium.
The recall was initiated because it has been determined that the pH of the recalled lots may not meet specification at expiry. This is a Class III recall, which indicates that the product is not likely to cause adverse health consequences.
Consumers and healthcare providers should stop using the affected lots and contact Oasis Medical, Inc. for further instructions or a refund.
The recalled product
- Product
- HPMC Visoelastic, 20,000 cps, Reference 5122, 515 (Private Label), 600102-001 (Private Label), 600103-001 (Private Label), 2.0 mL in 3-mL Syringe, OASIS Medical Inc, 514 South Vermont Avenue Glendora, CA 91741
- Manufacturer
- Oasis Medical, Inc.
- Category
- Medical Device — Ophthalmic
- Hazard
- Affected units
- 15,301
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Lot #: V0814H
- V0814J
- Exp 08/2016
- V1014L
- Exp 11/2016
- V1114A
- V0115G
- V0115H
- Exp 01/2017
- V0215A
- V0215B
- Exp 02/2017
- V0315G
- V0315H
- V0315O
- Exp 03/2017
- V0515C
- V0515D
- Exp 05/2017.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Oasis Medical, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Oasis Medical, Inc.
See all →- SevereOasis Tears PF Lubricant Eye Drops Recalled for Sterility Assurance
FDA (Drugs) · 2026-05-20
- LowOasis Medical Recalls HPMC Visoelastic Topical Due to pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls HPMC Visoelastic Due to Potential pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls ImproVue Ophthalmic Drops for pH Specification Failure
FDA (Drugs) · 2015-09-16
- LowOasis Medical Recalls ImproVue Ophthalmic Lubricant Drops for pH Failure
FDA (Drugs) · 2015-05-27
Same hazard · ph specification
See all →- LowFougera Recalls Triamcinolone Acetonide Lotion Due to pH Specification Concerns
FDA (Drugs) · 2014-07-23
- LowFougera Recalls Triamcinolone Acetonide Lotion Due to pH Specification Concerns
FDA (Drugs) · 2014-07-23